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Introduction
Patients with cirrhosis who are admitted to the ICU are
considered to have a poor prognosis. Previous studies
have sought to identify markers of high predictive value
in patients who will not survive their critical care stay
including the need for mechanical ventilation, vasopres-
sor support, GI bleeding and APACHE III score. These
studies have focused upon early prognosis, rather than
long term survival.
Objectives
We sought to validate previously described outcome
predictors and review long-term survival in a cohort of
cirrhotic patients admitted to the ICU.
Methods
We performed a retrospective analysis of cirrhotic
patients admitted to adult ICU, University Hospital of
Wales (Cardiff, UK) between 2009-14. Admission infor-
mation was collated from the Intensive Care National
Audit and Research Database. Child-Pugh, Model for
End-stage Liver Disease-Na (MELD-Na) and Acute Phy-
siology and Chronic Health Evaluation (APACHE II)
scores were derived from data on admission to critical
care. Statistical analyses were conducted with SPSS.
Results
One hundred and fifty one cirrhotics (2.8% of all critical
care admissions) were admited to the ICU with a mean
age of 54 (range 22-80) and a male preponderance
(65.6%). The predominant aetiology was alcoholic liver
disease (ALD, 107/151, 70.9%). The reason for ICU
admission were variceal bleed (29.8%); sepsis (25.2%);
decompensation (13.9%); non variceal bleed (5.3%) and
other (26%). ICU mortality was 43.7% for the 151
patients. Mean follow up after ICU discharge was 788
days (range 26-1722).
Hyponatraemia (p < 0.001), coagulopathy (p = 0.02),
APACHE II (p = 0.004) and MELD-Na scores (p < 0.001)
were significantly associated with mortality. Patients diag-
nosed as decompensation with no obvious underlying
precipitant had a worse prognosis than those with precipi-
tants (e.g. variceal bleeding, sepsis) which was maintained
at follow up (p = 0.05). Child´s A, B and C stage patients
had a mean overall survival of 1274, 976 and 690 days
respectively (p = 0.01).
Seventy eight patients were discharged from hospital.
Only 6 of these died, all with Child´s B liver disease. Only
attending outpatient follow up clinic was associated with
increased survival (p = 0.01, 1373 v 1668 days).
Conclusions
Nearly half of all cirrhotics admitted to the ICU die
before discharge, and two thirds of all patients have
alcohol as an aetiological factor, emphasizing the burden
on our society. As expected, commonly used scoring
systems predict short-term outcome, but often do not
reflect long-term survival.
Cirrhotics who survive the challenge of ICU admission
seem to have quite marked physiological resilence and
capacity for recovery with a good long term prognosis.
Interestingly only patients with Child´s B cirrhosis contin-
ued to demonstrate a post hospital discharge mortality,
warranting further investigation for underlying reasons.
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